Uncategorized
Glaukos iStent® Products to be Showcased at 2017 European Society of Cataract and Refractive Surgery
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, announced today that various Key Opinion Leader (KOL) presentations and electronic posters will feature its iStent® Trabecular Micro-Bypass and iStent inject® Trabecular Micro-Bypass products at the upcoming European Society of Cataract and Refrac